130 related articles for article (PubMed ID: 17547720)
1. Nephrogenic systemic fibrosis: is any contrast safe in renal failure?
Endre ZH
Intern Med J; 2007 Jul; 37(7):429-31. PubMed ID: 17547720
[No Abstract] [Full Text] [Related]
2. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Jamboti J
Intern Med J; 2007 Jul; 37(7):508-9; author reply 509. PubMed ID: 17547734
[No Abstract] [Full Text] [Related]
3. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
Cowper SE; Kuo PH; Bucala R
Arthritis Rheum; 2007 Oct; 56(10):3173-5. PubMed ID: 17907160
[No Abstract] [Full Text] [Related]
4. Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis.
Goveia M; Chan BP; Patel PR
J Am Acad Dermatol; 2007 Oct; 57(4):725-7. PubMed ID: 17689832
[No Abstract] [Full Text] [Related]
5. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.
Perazella MA; Rodby RA
Am J Med; 2007 Jul; 120(7):561-2. PubMed ID: 17602923
[No Abstract] [Full Text] [Related]
6. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Hamilton-Persaud K; Ezell LD; Macklin JG
Nephrol Nurs J; 2007; 34(3):283-7; quiz 288. PubMed ID: 17644872
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
Othersen JB; Maize JC; Woolson RF; Budisavljevic MN
Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis.
Kuo PH; Kanal E; Abu-Alfa AK; Cowper SE
Radiology; 2007 Mar; 242(3):647-9. PubMed ID: 17213364
[No Abstract] [Full Text] [Related]
9. Nephrogenic systemic fibrosis: an overview.
Cowper SE
J Am Coll Radiol; 2008 Jan; 5(1):23-8. PubMed ID: 18180005
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis--the beginning of the end?
Heymann WR
J Am Acad Dermatol; 2007 Jul; 57(1):171-2. PubMed ID: 17572281
[No Abstract] [Full Text] [Related]
11. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
Caccetta T; Chan JJ
Australas J Dermatol; 2008 Feb; 49(1):48-51. PubMed ID: 18186850
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis: a dermatologist's perspective.
Girardi M
J Am Coll Radiol; 2008 Jan; 5(1):40-4. PubMed ID: 18180008
[TBL] [Abstract][Full Text] [Related]
13. [Nephrogenic systemic fibrosis].
Cavallini L; Abaterusso C; Bedogna V; Pertica N; Loschiavo C; Lupo A
G Ital Nefrol; 2008; 25(1):14-20. PubMed ID: 18264914
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium and nephrogenic systemic fibrosis: association or causation.
Kurtkoti J; Snow T; Hiremagalur B
Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
Canavese C; Mereu MC; Aime S; Lazzarich E; Fenoglio R; Quaglia M; Stratta P
J Nephrol; 2008; 21(3):324-36. PubMed ID: 18587720
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis in patients undergoing hemodialysis: comment on the article by Todd et al.
Boehm I
Arthritis Rheum; 2008 Mar; 58(3):910; author reply 910-1. PubMed ID: 18311835
[No Abstract] [Full Text] [Related]
17. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminases: the missing link in nephrogenic systemic fibrosis.
Parsons AC; Yosipovitch G; Sheehan DJ; Sangüeza OP; Greenberg CS; Sane DC
Am J Dermatopathol; 2007 Oct; 29(5):433-6. PubMed ID: 17890909
[TBL] [Abstract][Full Text] [Related]
19. [Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
van der Meij N; Keur I; van Lienden KP; Scheepstra CG; Bos JD
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2898-903. PubMed ID: 18257437
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
